MABWORKS
Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia.
MABWORKS
Industry:
Biopharma Biotechnology Clinical Trials
Founded:
2003-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.mab-works.com
Total Employee:
11+
Status:
Active
Contact:
+86(0)01-87169780
Total Funding:
214.51 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apple Mobile Web Clips Icon Mobile Non Scaleable Content Nginx Euro IPv6 PHP PHP 7
Current Employees Featured
Investors List
Lake Bleu Capital
Lake Bleu Capital investment in Series C - Mabworks
CITIC Securities
CITIC Securities investment in Series C - Mabworks
Beijing E-town International Investment & Development
Beijing E-town International Investment & Development investment in Series C - Mabworks
BOCOM International
BOCOM International investment in Series C - Mabworks
Sealand Securities
Sealand Securities investment in Series C - Mabworks
Guangzhou Yuexiu Financial Holdings
Guangzhou Yuexiu Financial Holdings investment in Series C - Mabworks
LYZZ Capital
LYZZ Capital investment in Series C - Mabworks
CICC
CICC investment in Series C - Mabworks
SDIC Fund Management
SDIC Fund Management investment in Series C - Mabworks
Harvest Global Investments
Harvest Global Investments investment in Series B - Mabworks
Official Site Inspections
http://www.mab-works.com Semrush global rank: 7.27 M Semrush visits lastest month: 548
- Host name: hn.kd.ny.adsl
- IP address: 42.236.91.228
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai
